Leading the Way in Life Science Technologies

GEN Exclusives

More »

The Lists

More »
Sep 4, 2012

Top 20 Pharma-Friendly Congress Members

Who accepted the biggest pharmaceutical company contributions? Find out here.

Top 20 Pharma-Friendly Congress Members

These politicians accepted the most pharma dollars toward their campaigns. [© Ljupco Smokovski - Fotolia.com]

  • #10. Rep. Leonard Lance (R-NJ)

    Total contributions: $93,250

  • #9. Rep. Anna G. Eshoo (D-CA)

    Total contributions: $104,950

  • #8. Rep. John Boehner (R-OH)

    Total contributions: $112,000

  • #7. Sen. Joe Manchin (D-WV)

    Total contributions: $116,500

  • #6. Sen. Robert P. Casey Jr. (D-PA)

    Total contributions: $116,830

  • #5. Sen. Robert Menendez (D-NJ)

    Total contributions: $122,050

  • #4. Sen. Scott Brown (R-MA)

    Total contributions: $123,953

  • #3. Sen. Orrin G. Hatch (R-UT)

    Total contributions: $159,400

  • #2. Rep. Fred Upton (R-MI)

    Total contributions: $162,865

  • #1. Rep. Eric Cantor (R-VA)

    Total contributions: $173,500


    Leave a comment by clicking the “Comments” icon. We want to hear your thoughts!

Related content

Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »